ThinkSabio

$PRME

$3.00▲ +0.7% YTD

3 SEC 13D/G filings tracked · Last updated Oct 5, 2026

Filing History
News
PRME ▲ +0.7% - Prime Medicine, Inc.
CP $3.00▲ +0.7%Oct 5, 2026 · ThinkSabio Blog

$PRME - Prime Medicine Announces First Patient Dosed in Global Phase 1/2 Clinical Trial of PM577a for H1069Q-Mutated Wilson Disease…

News
PRME ▲ +10.2% - Prime Medicine, Inc.
CP $3.45▲ +10.2%Sep 24, 2026 · ThinkSabio Blog

$PRME Prime Medicine Announces U.S. FDA Clearance of Investigational New Drug Application for PM647 in Alpha-1 Antitrypsin Deficiency…

News
PRME ▼ -0.5% - Prime Medicine, Inc.
CP $3.67▲ -0.5%Sep 3, 2026 · ThinkSabio Blog

$PRME - Prime Medicine to Participate in Upcoming Investor Conferences…